nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.125	0.162	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0834	0.108	CbGbCtD
Ondansetron—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0834	0.108	CbGbCtD
Ondansetron—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0805	0.104	CbGbCtD
Ondansetron—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0645	0.0832	CbGbCtD
Ondansetron—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0626	0.0807	CbGbCtD
Ondansetron—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0489	0.063	CbGbCtD
Ondansetron—CYP2C9—Dexamethasone—ankylosing spondylitis	0.042	0.0541	CbGbCtD
Ondansetron—CYP3A4—Betamethasone—ankylosing spondylitis	0.042	0.0541	CbGbCtD
Ondansetron—CYP3A4—Prednisolone—ankylosing spondylitis	0.0414	0.0533	CbGbCtD
Ondansetron—CYP3A4—Prednisone—ankylosing spondylitis	0.0391	0.0504	CbGbCtD
Ondansetron—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0384	0.0495	CbGbCtD
Ondansetron—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0244	0.0315	CbGbCtD
Ondansetron—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000811	0.00362	CcSEcCtD
Ondansetron—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000811	0.00362	CcSEcCtD
Ondansetron—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000809	0.00361	CcSEcCtD
Ondansetron—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000805	0.00359	CcSEcCtD
Ondansetron—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000803	0.00358	CcSEcCtD
Ondansetron—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000798	0.00356	CcSEcCtD
Ondansetron—Vision blurred—Prednisolone—ankylosing spondylitis	0.000797	0.00356	CcSEcCtD
Ondansetron—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000796	0.00355	CcSEcCtD
Ondansetron—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000787	0.00351	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000785	0.0035	CcSEcCtD
Ondansetron—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000781	0.00349	CcSEcCtD
Ondansetron—Visual impairment—Betamethasone—ankylosing spondylitis	0.000781	0.00349	CcSEcCtD
Ondansetron—Erythema—Triamcinolone—ankylosing spondylitis	0.000778	0.00347	CcSEcCtD
Ondansetron—Erythema—Methylprednisolone—ankylosing spondylitis	0.000776	0.00346	CcSEcCtD
Ondansetron—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000775	0.00346	CcSEcCtD
Ondansetron—Angioedema—Prednisolone—ankylosing spondylitis	0.000773	0.00345	CcSEcCtD
Ondansetron—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000771	0.00344	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000768	0.00343	CcSEcCtD
Ondansetron—Malaise—Prednisolone—ankylosing spondylitis	0.000763	0.0034	CcSEcCtD
Ondansetron—Syncope—Prednisolone—ankylosing spondylitis	0.000758	0.00338	CcSEcCtD
Ondansetron—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000758	0.00338	CcSEcCtD
Ondansetron—Eye disorder—Betamethasone—ankylosing spondylitis	0.000758	0.00338	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000743	0.00332	CcSEcCtD
Ondansetron—Asthma—Methotrexate—ankylosing spondylitis	0.000737	0.00329	CcSEcCtD
Ondansetron—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000735	0.00328	CcSEcCtD
Ondansetron—Angiopathy—Betamethasone—ankylosing spondylitis	0.000735	0.00328	CcSEcCtD
Ondansetron—Convulsion—Prednisolone—ankylosing spondylitis	0.000733	0.00327	CcSEcCtD
Ondansetron—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000724	0.00323	CcSEcCtD
Ondansetron—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000724	0.00323	CcSEcCtD
Ondansetron—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000722	0.00322	CcSEcCtD
Ondansetron—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00072	0.00321	CcSEcCtD
Ondansetron—Bradycardia—Prednisone—ankylosing spondylitis	0.000719	0.00321	CcSEcCtD
Ondansetron—Discomfort—Prednisolone—ankylosing spondylitis	0.000711	0.00317	CcSEcCtD
Ondansetron—Angioedema—Triamcinolone—ankylosing spondylitis	0.000711	0.00317	CcSEcCtD
Ondansetron—Haemoglobin—Prednisone—ankylosing spondylitis	0.00071	0.00317	CcSEcCtD
Ondansetron—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000709	0.00316	CcSEcCtD
Ondansetron—Haemorrhage—Prednisone—ankylosing spondylitis	0.000706	0.00315	CcSEcCtD
Ondansetron—Erythema—Dexamethasone—ankylosing spondylitis	0.000706	0.00315	CcSEcCtD
Ondansetron—Erythema—Betamethasone—ankylosing spondylitis	0.000706	0.00315	CcSEcCtD
Ondansetron—Malaise—Triamcinolone—ankylosing spondylitis	0.000701	0.00313	CcSEcCtD
Ondansetron—Malaise—Methylprednisolone—ankylosing spondylitis	0.0007	0.00312	CcSEcCtD
Ondansetron—Syncope—Triamcinolone—ankylosing spondylitis	0.000697	0.00311	CcSEcCtD
Ondansetron—Syncope—Methylprednisolone—ankylosing spondylitis	0.000696	0.00311	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00069	0.00308	CcSEcCtD
Ondansetron—Dysuria—Methotrexate—ankylosing spondylitis	0.000689	0.00308	CcSEcCtD
Ondansetron—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000684	0.00305	CcSEcCtD
Ondansetron—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000682	0.00304	CcSEcCtD
Ondansetron—Shock—Prednisolone—ankylosing spondylitis	0.000679	0.00303	CcSEcCtD
Ondansetron—Cough—Triamcinolone—ankylosing spondylitis	0.000679	0.00303	CcSEcCtD
Ondansetron—Convulsion—Triamcinolone—ankylosing spondylitis	0.000674	0.00301	CcSEcCtD
Ondansetron—Tachycardia—Prednisolone—ankylosing spondylitis	0.000674	0.00301	CcSEcCtD
Ondansetron—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000672	0.003	CcSEcCtD
Ondansetron—Eye disorder—Prednisone—ankylosing spondylitis	0.00066	0.00294	CcSEcCtD
Ondansetron—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000658	0.00294	CcSEcCtD
Ondansetron—Drowsiness—Methotrexate—ankylosing spondylitis	0.000657	0.00293	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000656	0.00293	CcSEcCtD
Ondansetron—Flushing—Prednisone—ankylosing spondylitis	0.000655	0.00292	CcSEcCtD
Ondansetron—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000655	0.00292	CcSEcCtD
Ondansetron—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000655	0.00292	CcSEcCtD
Ondansetron—Discomfort—Triamcinolone—ankylosing spondylitis	0.000654	0.00292	CcSEcCtD
Ondansetron—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000653	0.00291	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000652	0.00291	CcSEcCtD
Ondansetron—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000648	0.00289	CcSEcCtD
Ondansetron—Angioedema—Dexamethasone—ankylosing spondylitis	0.000645	0.00288	CcSEcCtD
Ondansetron—Angioedema—Betamethasone—ankylosing spondylitis	0.000645	0.00288	CcSEcCtD
Ondansetron—Angiopathy—Prednisone—ankylosing spondylitis	0.000641	0.00286	CcSEcCtD
Ondansetron—Immune system disorder—Prednisone—ankylosing spondylitis	0.000638	0.00285	CcSEcCtD
Ondansetron—Malaise—Dexamethasone—ankylosing spondylitis	0.000636	0.00284	CcSEcCtD
Ondansetron—Malaise—Betamethasone—ankylosing spondylitis	0.000636	0.00284	CcSEcCtD
Ondansetron—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000635	0.00283	CcSEcCtD
Ondansetron—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000633	0.00283	CcSEcCtD
Ondansetron—Syncope—Dexamethasone—ankylosing spondylitis	0.000633	0.00282	CcSEcCtD
Ondansetron—Syncope—Betamethasone—ankylosing spondylitis	0.000633	0.00282	CcSEcCtD
Ondansetron—Arrhythmia—Prednisone—ankylosing spondylitis	0.000631	0.00281	CcSEcCtD
Ondansetron—Shock—Triamcinolone—ankylosing spondylitis	0.000624	0.00279	CcSEcCtD
Ondansetron—Shock—Methylprednisolone—ankylosing spondylitis	0.000623	0.00278	CcSEcCtD
Ondansetron—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000622	0.00277	CcSEcCtD
Ondansetron—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000621	0.00277	CcSEcCtD
Ondansetron—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00062	0.00277	CcSEcCtD
Ondansetron—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00062	0.00277	CcSEcCtD
Ondansetron—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00062	0.00277	CcSEcCtD
Ondansetron—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000619	0.00276	CcSEcCtD
Ondansetron—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000618	0.00276	CcSEcCtD
Ondansetron—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000615	0.00275	CcSEcCtD
Ondansetron—Erythema—Prednisone—ankylosing spondylitis	0.000615	0.00274	CcSEcCtD
Ondansetron—Convulsion—Dexamethasone—ankylosing spondylitis	0.000611	0.00273	CcSEcCtD
Ondansetron—Convulsion—Betamethasone—ankylosing spondylitis	0.000611	0.00273	CcSEcCtD
Ondansetron—Anxiety—Betamethasone—ankylosing spondylitis	0.000599	0.00267	CcSEcCtD
Ondansetron—Anxiety—Dexamethasone—ankylosing spondylitis	0.000599	0.00267	CcSEcCtD
Ondansetron—Discomfort—Betamethasone—ankylosing spondylitis	0.000594	0.00265	CcSEcCtD
Ondansetron—Discomfort—Dexamethasone—ankylosing spondylitis	0.000594	0.00265	CcSEcCtD
Ondansetron—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000593	0.00265	CcSEcCtD
Ondansetron—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000592	0.00264	CcSEcCtD
Ondansetron—Pain—Prednisolone—ankylosing spondylitis	0.00059	0.00263	CcSEcCtD
Ondansetron—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00059	0.00263	CcSEcCtD
Ondansetron—Vision blurred—Prednisone—ankylosing spondylitis	0.000579	0.00258	CcSEcCtD
Ondansetron—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000576	0.00257	CcSEcCtD
Ondansetron—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000576	0.00257	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00057	0.00254	CcSEcCtD
Ondansetron—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00057	0.00254	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000569	0.00254	CcSEcCtD
Ondansetron—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000569	0.00254	CcSEcCtD
Ondansetron—Visual impairment—Methotrexate—ankylosing spondylitis	0.000569	0.00254	CcSEcCtD
Ondansetron—Shock—Dexamethasone—ankylosing spondylitis	0.000567	0.00253	CcSEcCtD
Ondansetron—Shock—Betamethasone—ankylosing spondylitis	0.000567	0.00253	CcSEcCtD
Ondansetron—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000566	0.00253	CcSEcCtD
Ondansetron—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000565	0.00252	CcSEcCtD
Ondansetron—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000565	0.00252	CcSEcCtD
Ondansetron—Agitation—Prednisone—ankylosing spondylitis	0.000565	0.00252	CcSEcCtD
Ondansetron—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000562	0.00251	CcSEcCtD
Ondansetron—Tachycardia—Betamethasone—ankylosing spondylitis	0.000562	0.00251	CcSEcCtD
Ondansetron—Angioedema—Prednisone—ankylosing spondylitis	0.000562	0.00251	CcSEcCtD
Ondansetron—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000558	0.00249	CcSEcCtD
Ondansetron—Malaise—Prednisone—ankylosing spondylitis	0.000554	0.00247	CcSEcCtD
Ondansetron—Eye disorder—Methotrexate—ankylosing spondylitis	0.000551	0.00246	CcSEcCtD
Ondansetron—Syncope—Prednisone—ankylosing spondylitis	0.000551	0.00246	CcSEcCtD
Ondansetron—Urticaria—Prednisolone—ankylosing spondylitis	0.000548	0.00245	CcSEcCtD
Ondansetron—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000548	0.00244	CcSEcCtD
Ondansetron—Fatigue—Triamcinolone—ankylosing spondylitis	0.000547	0.00244	CcSEcCtD
Ondansetron—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000546	0.00244	CcSEcCtD
Ondansetron—Pain—Triamcinolone—ankylosing spondylitis	0.000543	0.00242	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00054	0.00241	CcSEcCtD
Ondansetron—Hypotension—Betamethasone—ankylosing spondylitis	0.000538	0.0024	CcSEcCtD
Ondansetron—Hypotension—Dexamethasone—ankylosing spondylitis	0.000538	0.0024	CcSEcCtD
Ondansetron—Angiopathy—Methotrexate—ankylosing spondylitis	0.000535	0.00239	CcSEcCtD
Ondansetron—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000533	0.00238	CcSEcCtD
Ondansetron—Convulsion—Prednisone—ankylosing spondylitis	0.000532	0.00238	CcSEcCtD
Ondansetron—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000532	0.00237	CcSEcCtD
Ondansetron—Chills—Methotrexate—ankylosing spondylitis	0.000529	0.00236	CcSEcCtD
Ondansetron—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000523	0.00233	CcSEcCtD
Ondansetron—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000522	0.00233	CcSEcCtD
Ondansetron—Anxiety—Prednisone—ankylosing spondylitis	0.000521	0.00233	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00052	0.00232	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000518	0.00231	CcSEcCtD
Ondansetron—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000517	0.00231	CcSEcCtD
Ondansetron—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000517	0.00231	CcSEcCtD
Ondansetron—Discomfort—Prednisone—ankylosing spondylitis	0.000517	0.00231	CcSEcCtD
Ondansetron—Erythema—Methotrexate—ankylosing spondylitis	0.000514	0.00229	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000509	0.00227	CcSEcCtD
Ondansetron—Urticaria—Triamcinolone—ankylosing spondylitis	0.000504	0.00225	CcSEcCtD
Ondansetron—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000503	0.00225	CcSEcCtD
Ondansetron—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000502	0.00224	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000502	0.00224	CcSEcCtD
Ondansetron—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000501	0.00223	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000497	0.00222	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000497	0.00222	CcSEcCtD
Ondansetron—Fatigue—Betamethasone—ankylosing spondylitis	0.000497	0.00222	CcSEcCtD
Ondansetron—Fatigue—Dexamethasone—ankylosing spondylitis	0.000497	0.00222	CcSEcCtD
Ondansetron—Shock—Prednisone—ankylosing spondylitis	0.000493	0.0022	CcSEcCtD
Ondansetron—Pain—Dexamethasone—ankylosing spondylitis	0.000493	0.0022	CcSEcCtD
Ondansetron—Pain—Betamethasone—ankylosing spondylitis	0.000493	0.0022	CcSEcCtD
Ondansetron—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000492	0.00219	CcSEcCtD
Ondansetron—Tachycardia—Prednisone—ankylosing spondylitis	0.00049	0.00218	CcSEcCtD
Ondansetron—Skin disorder—Prednisone—ankylosing spondylitis	0.000487	0.00217	CcSEcCtD
Ondansetron—Vision blurred—Methotrexate—ankylosing spondylitis	0.000484	0.00216	CcSEcCtD
Ondansetron—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000477	0.00213	CcSEcCtD
Ondansetron—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000475	0.00212	CcSEcCtD
Ondansetron—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000475	0.00212	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000471	0.0021	CcSEcCtD
Ondansetron—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000471	0.0021	CcSEcCtD
Ondansetron—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000468	0.00209	CcSEcCtD
Ondansetron—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000467	0.00208	CcSEcCtD
Ondansetron—Malaise—Methotrexate—ankylosing spondylitis	0.000463	0.00207	CcSEcCtD
Ondansetron—Urticaria—Dexamethasone—ankylosing spondylitis	0.000458	0.00204	CcSEcCtD
Ondansetron—Urticaria—Betamethasone—ankylosing spondylitis	0.000458	0.00204	CcSEcCtD
Ondansetron—Dizziness—Prednisolone—ankylosing spondylitis	0.000456	0.00204	CcSEcCtD
Ondansetron—Asthenia—Triamcinolone—ankylosing spondylitis	0.000455	0.00203	CcSEcCtD
Ondansetron—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000455	0.00203	CcSEcCtD
Ondansetron—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000455	0.00203	CcSEcCtD
Ondansetron—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000455	0.00203	CcSEcCtD
Ondansetron—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000455	0.00203	CcSEcCtD
Ondansetron—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000454	0.00203	CcSEcCtD
Ondansetron—Paraesthesia—Prednisone—ankylosing spondylitis	0.00045	0.00201	CcSEcCtD
Ondansetron—Pruritus—Triamcinolone—ankylosing spondylitis	0.000449	0.002	CcSEcCtD
Ondansetron—Cough—Methotrexate—ankylosing spondylitis	0.000448	0.002	CcSEcCtD
Ondansetron—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000448	0.002	CcSEcCtD
Ondansetron—Convulsion—Methotrexate—ankylosing spondylitis	0.000445	0.00199	CcSEcCtD
Ondansetron—Chest pain—Methotrexate—ankylosing spondylitis	0.000437	0.00195	CcSEcCtD
Ondansetron—Rash—Prednisolone—ankylosing spondylitis	0.000435	0.00194	CcSEcCtD
Ondansetron—Dermatitis—Prednisolone—ankylosing spondylitis	0.000435	0.00194	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000434	0.00194	CcSEcCtD
Ondansetron—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000433	0.00193	CcSEcCtD
Ondansetron—Fatigue—Prednisone—ankylosing spondylitis	0.000432	0.00193	CcSEcCtD
Ondansetron—Headache—Prednisolone—ankylosing spondylitis	0.000432	0.00193	CcSEcCtD
Ondansetron—Discomfort—Methotrexate—ankylosing spondylitis	0.000432	0.00193	CcSEcCtD
Ondansetron—Constipation—Prednisone—ankylosing spondylitis	0.000429	0.00191	CcSEcCtD
Ondansetron—Dizziness—Triamcinolone—ankylosing spondylitis	0.00042	0.00187	CcSEcCtD
Ondansetron—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000419	0.00187	CcSEcCtD
Ondansetron—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000419	0.00187	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000413	0.00184	CcSEcCtD
Ondansetron—Asthenia—Dexamethasone—ankylosing spondylitis	0.000413	0.00184	CcSEcCtD
Ondansetron—Asthenia—Betamethasone—ankylosing spondylitis	0.000413	0.00184	CcSEcCtD
Ondansetron—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000411	0.00183	CcSEcCtD
Ondansetron—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00041	0.00183	CcSEcCtD
Ondansetron—Pruritus—Dexamethasone—ankylosing spondylitis	0.000407	0.00182	CcSEcCtD
Ondansetron—Pruritus—Betamethasone—ankylosing spondylitis	0.000407	0.00182	CcSEcCtD
Ondansetron—Skin disorder—Methotrexate—ankylosing spondylitis	0.000407	0.00182	CcSEcCtD
Ondansetron—Vomiting—Triamcinolone—ankylosing spondylitis	0.000404	0.0018	CcSEcCtD
Ondansetron—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000403	0.0018	CcSEcCtD
Ondansetron—Rash—Triamcinolone—ankylosing spondylitis	0.0004	0.00179	CcSEcCtD
Ondansetron—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0004	0.00178	CcSEcCtD
Ondansetron—Rash—Methylprednisolone—ankylosing spondylitis	0.000399	0.00178	CcSEcCtD
Ondansetron—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000399	0.00178	CcSEcCtD
Ondansetron—Urticaria—Prednisone—ankylosing spondylitis	0.000398	0.00178	CcSEcCtD
Ondansetron—Headache—Triamcinolone—ankylosing spondylitis	0.000398	0.00177	CcSEcCtD
Ondansetron—Headache—Methylprednisolone—ankylosing spondylitis	0.000397	0.00177	CcSEcCtD
Ondansetron—Abdominal pain—Prednisone—ankylosing spondylitis	0.000396	0.00177	CcSEcCtD
Ondansetron—Body temperature increased—Prednisone—ankylosing spondylitis	0.000396	0.00177	CcSEcCtD
Ondansetron—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000394	0.00176	CcSEcCtD
Ondansetron—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000394	0.00176	CcSEcCtD
Ondansetron—Hypotension—Methotrexate—ankylosing spondylitis	0.000392	0.00175	CcSEcCtD
Ondansetron—Dizziness—Dexamethasone—ankylosing spondylitis	0.000381	0.0017	CcSEcCtD
Ondansetron—Dizziness—Betamethasone—ankylosing spondylitis	0.000381	0.0017	CcSEcCtD
Ondansetron—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000376	0.00168	CcSEcCtD
Ondansetron—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000374	0.00167	CcSEcCtD
Ondansetron—Somnolence—Methotrexate—ankylosing spondylitis	0.000373	0.00166	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00037	0.00165	CcSEcCtD
Ondansetron—Vomiting—Dexamethasone—ankylosing spondylitis	0.000366	0.00163	CcSEcCtD
Ondansetron—Vomiting—Betamethasone—ankylosing spondylitis	0.000366	0.00163	CcSEcCtD
Ondansetron—Rash—Dexamethasone—ankylosing spondylitis	0.000363	0.00162	CcSEcCtD
Ondansetron—Rash—Betamethasone—ankylosing spondylitis	0.000363	0.00162	CcSEcCtD
Ondansetron—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000363	0.00162	CcSEcCtD
Ondansetron—Dermatitis—Betamethasone—ankylosing spondylitis	0.000363	0.00162	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000362	0.00161	CcSEcCtD
Ondansetron—Fatigue—Methotrexate—ankylosing spondylitis	0.000361	0.00161	CcSEcCtD
Ondansetron—Headache—Dexamethasone—ankylosing spondylitis	0.000361	0.00161	CcSEcCtD
Ondansetron—Headache—Betamethasone—ankylosing spondylitis	0.000361	0.00161	CcSEcCtD
Ondansetron—Asthenia—Prednisone—ankylosing spondylitis	0.00036	0.00161	CcSEcCtD
Ondansetron—Pain—Methotrexate—ankylosing spondylitis	0.000358	0.0016	CcSEcCtD
Ondansetron—Pruritus—Prednisone—ankylosing spondylitis	0.000355	0.00158	CcSEcCtD
Ondansetron—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000345	0.00154	CcSEcCtD
Ondansetron—Diarrhoea—Prednisone—ankylosing spondylitis	0.000343	0.00153	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000343	0.00153	CcSEcCtD
Ondansetron—Urticaria—Methotrexate—ankylosing spondylitis	0.000333	0.00149	CcSEcCtD
Ondansetron—Dizziness—Prednisone—ankylosing spondylitis	0.000332	0.00148	CcSEcCtD
Ondansetron—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000331	0.00148	CcSEcCtD
Ondansetron—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000331	0.00148	CcSEcCtD
Ondansetron—Vomiting—Prednisone—ankylosing spondylitis	0.000319	0.00142	CcSEcCtD
Ondansetron—Rash—Prednisone—ankylosing spondylitis	0.000316	0.00141	CcSEcCtD
Ondansetron—Dermatitis—Prednisone—ankylosing spondylitis	0.000316	0.00141	CcSEcCtD
Ondansetron—Headache—Prednisone—ankylosing spondylitis	0.000314	0.0014	CcSEcCtD
Ondansetron—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000309	0.00138	CcSEcCtD
Ondansetron—Asthenia—Methotrexate—ankylosing spondylitis	0.000301	0.00134	CcSEcCtD
Ondansetron—Pruritus—Methotrexate—ankylosing spondylitis	0.000297	0.00132	CcSEcCtD
Ondansetron—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000287	0.00128	CcSEcCtD
Ondansetron—Dizziness—Methotrexate—ankylosing spondylitis	0.000277	0.00124	CcSEcCtD
Ondansetron—Vomiting—Methotrexate—ankylosing spondylitis	0.000267	0.00119	CcSEcCtD
Ondansetron—Rash—Methotrexate—ankylosing spondylitis	0.000264	0.00118	CcSEcCtD
Ondansetron—Dermatitis—Methotrexate—ankylosing spondylitis	0.000264	0.00118	CcSEcCtD
Ondansetron—Headache—Methotrexate—ankylosing spondylitis	0.000263	0.00117	CcSEcCtD
